Industry

Diddy will pay $185 million for legal weed operations in 3 states

Published on November 4, 2022
sean diddy combs photo cresco columbia care
(AP)

The deal will pass Cresco Labs and Columbia Care assets in New York and Illinois to the mogul formerly known as Puffy. The new, unnamed company will be America’s largest Black-owned and operated multi-state cannabis pipeline.


Hip-Hop and business mogul Sean “Diddy” Combs, is taking over wholesale and retail cannabis operations in three major state markets.

According to a news release sent out Friday (November 4), Combs has made a deal with Cresco Labs and Columbia Care to take over operations in Illinois, Massachusetts, and New York. The states are home to major markets like Chicago and Boston, and New York City, which is scheduled to launch adult-use cannabis sales at the end of 2022.

The acquisition will make Combs’ new company the world’s largest Black cannabis operator, according to the release. The release also claims that the assets he is acquiring will make his new company America’s first minority-owned, vertically-integrated cannabis operation, commonly referred to as an MSO, or multi-state operation.

Combs joins fellow musicians-turned-moguls JAY-Z, Wiz Khalifa, and Cookies CEO Berner in the legal cannabis industry, one of America’s fastest-growing sectors.

Related
Tracing Cookies’ evolution from The Bay to the Big Apple

“Owning the entire process — from growing and manufacturing to marketing, retail, and wholesale distribution — is a historic win for the culture that will allow us to empower diverse leaders throughout the ecosystem and be bold advocates for inclusion.”

Sean “Diddy” Combs

What are the terms of Combs’ new weed deal?

Combs, Cresco, and Columbia Care have reportedly signed definitive agreements to divest some New York, Illinois, and Massachusetts assets to an undisclosed entity that is owned and controlled by Sean “Diddy” Combs.

Once the deal closes, Combs will be poised to operate wholesale and retail operations in New York City, Boston, and Chicago, some of the cannabis industry’s most valuable legal markets.

NYC is projected to make $1.3 billion in sales by 2023, and in Massachusetts, the plant just surpassed cranberries as the state’s most valuable cash crop.

Related
Legal cannabis is America’s 6th biggest cash crop

It’s not yet clear how or when the Mount Vernon and Harlem, New York native will enter the New York City market, which will be heavily influenced by state mandates that require New Yorkers with cannabis convictions to be the first with licensed adult-use stores.

This transaction is required for Cresco to close its previously announced acquisition of Columbia Care. The transaction will become official when Cresco’s acquisition of Columbia Care goes through. The reported purchase price is roughly $185 million. Combs will reportedly pay $110 million in cash and $75 million in debt to complete the acquisition.

The billionaire buds club is growing

Last week, Zack O’Malley Greenberg and Rolling Stone reported that the world’s five wealthiest rappers list included Combs ($1 billion), JAY-Z ($1.5 billion), and Berner ($410 million). Berner’s inclusion was shocking to many since most of his wealth stems from legal cannabis, not music or more mainstream consumer goods, like clothing, spirits, or media—all fields Diddy has cultivated success in.

Shop highly rated stores near you

Showing you stores near
See all stores

JAY-Z is already heavily-invested in cannabis through his Monogram brand and Parent Co. holding company. And Diddy’s son, Justin Combs, recently brought his own strain, Honey Combs, to California dispensaries through a partnership with Joke’s Up.

Did Diddy see Berner gaining ground on him in the billionaire standings and make a few quick calls to regain steam? It’s hard to say for sure. For now, there’s no telling how long this deal was in the works, or when operations will begin. As more details become available, Leafly will give updates on this major moment for the mainstreaming of legal cannabis.

Here’s what Combs, Cresco, and Columbia Care had to say

“Today’s announcement is bigger than the Transaction – and it couldn’t come at a time of greater significance and momentum. We’ve seen executive power exercised to address matters of cannabis injustice, we’re seeing bi-partisan support for elements of federal reform, and we’re seeing some of the largest and most influential states in the country launch cannabis programs prioritizing social responsibility – this announcement adds to that momentum.”

Charles Bachtell, Cresco Labs’ CEO

Columbia Care CEO and Co-founder, Nicholas Vita, said, “These assets offer the Combs’ team significant market presence, enabling them to make the most impact on the industry as a whole. It’s been clear to us that Sean has the right team to carry on the strong legacy of these Columbia Care and Cresco Labs facilities, and we can’t wait to see how he helps shape the cannabis industry going forward through his entrepreneurial leadership and innovation.”

Cresco Labs’ CEO Charles Bachtell said the transaction “is a major step towards closing the Columbia Care acquisition and our leadership position in one of the largest consumer products categories of the future. For an industry in need of greater diversity of leadership and perspective, the substantial presence of a minority-owned operator in some of the most influential markets in the country being led by one of the most prolific and impactful entrepreneurs of our time is momentous…and incredibly exciting. We’re thrilled to welcome Sean and his team to the industry.”

“My mission has always been to create opportunities for Black entrepreneurs in industries where we’ve traditionally been denied access, and this acquisition provides the immediate scale and impact needed to create a more equitable future in cannabis.”

Sean “Diddy” Combs

Puff, Puff, take that!

Shop highly rated stores near you

Showing you stores near
See all stores
Calvin Stovall
Calvin Stovall
Calvin Stovall is Leafly's East Coast Editor.
View Calvin Stovall's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




The material provided on Leafly is intended for educational and informational purposes only. Leafly is not engaged in rendering medical service or advice and the information provided is not a substitute for a professional medical opinion. If you have a medical problem, please contact a qualified health professional.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.